Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Online Left-hemispheric Frontoparietal Theta In-phase tACS During Working Memory Training in Schizophrenia Patients: A Pilot Randomized Double-blind, Sham-controlled Study of the Effects on Negative Symptoms
This study has finished and is no longer accepting participants.
In Taipei
Tocilizumab, An IL-6 Receptor Antibody, As Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
This study has finished and is no longer accepting participants.
In New YorkTopiramate in Treatment Refractory Psychotic Illness: Effects on Weight Gain and Psychopathology
This study is no longer accepting new participants.
In TorontoClinical Trial to Assess Transcranial Current Stimulation as a Treatment for Medication Refractory Auditory Hallucinations in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Chapel HillResearchers are comparing magnetic stimulation of the brain and a simulated comparison procedure to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
In New York
Schizophrenia Patient and Family Continuity of Care
This study has finished and is no longer accepting participants.
In PittsburghA Multicentre, Placebo-controlled Trial of Eicosapentaenoic Acid (EPA) and Antioxidant Supplementation in the Treatment of Schizophrenia and Related Disorders
This study has finished and is no longer accepting participants.
In OsloThis study evaluated the safety of Bifeprunox for people with schizophrenia.
This study has finished and is no longer accepting participants.
In National CityThis study assessed thinking abilities.
This study has finished and is no longer accepting participants.
In DelhiValidity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including AlicanteSensoril® (Ashwagandha), an Immunomodulator and Anti-inflammatory Agent for Schizophrenia: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study
This study has finished and is no longer accepting participants.
In Pittsburgh
Work Activity Augmented by Cognitive Rehabilitation: Continuation and Follow-up
This study has finished and is no longer accepting participants.
In West HavenWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.